Other featured articles
Medicare Advantage Enrolls Lower-Spending People, Leading to Large Overpayments
Favorable selection led to Medicare Advantage overpayments on the order of 14.4% in 2020.
Benefits of Medicare Coverage for Weight Loss Drugs
The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
This paper provides three recommendations to steer the potential effects of the IRA toward its goal of improving patient access while encouraging innovation.
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
Current cancer-screening and reimbursement paradigms should be revised to recognize the value of new technologies available.